ARTICLE | Company News
Arius, Genentech cancer antibody deal
March 23, 2006 3:08 AM UTC
Arius (TSX-V:ARI) granted DNA exclusive worldwide rights to develop and commercialize a family of research-stage cancer antibodies. The antibodies were developed using ARI's FunctionFirst highthroughp...